207_Combined course Presentations

Future Perspectives…

RTOG 1306 trial – “ALLIANCE” Induction therapy with TKIs in “oncogene addicted” NSCLC

Patient population 

Histologically confirmed non-squamous NSCLC



Unresectable stage IIIA-IIIB disease



Surgically staged to confirm N2 or N3 disease